[go: up one dir, main page]

DK2952178T3 - Oftalmiske sammensætninger og fremgangsmåder til behandling af øjne - Google Patents

Oftalmiske sammensætninger og fremgangsmåder til behandling af øjne Download PDF

Info

Publication number
DK2952178T3
DK2952178T3 DK15176046.9T DK15176046T DK2952178T3 DK 2952178 T3 DK2952178 T3 DK 2952178T3 DK 15176046 T DK15176046 T DK 15176046T DK 2952178 T3 DK2952178 T3 DK 2952178T3
Authority
DK
Denmark
Prior art keywords
treatment methods
ophthalmic compositions
eye treatment
eye
ophthalmic
Prior art date
Application number
DK15176046.9T
Other languages
English (en)
Inventor
Joseph G Vehige
Peter A Simmons
Joan-En Chang-Lin
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36218032&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2952178(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of DK2952178T3 publication Critical patent/DK2952178T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1732—Lectins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK15176046.9T 2004-11-16 2005-11-14 Oftalmiske sammensætninger og fremgangsmåder til behandling af øjne DK2952178T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/990,811 US8569367B2 (en) 2004-11-16 2004-11-16 Ophthalmic compositions and methods for treating eyes
EP05821259.8A EP1811959B2 (en) 2004-11-16 2005-11-14 Ophthalmic compositions

Publications (1)

Publication Number Publication Date
DK2952178T3 true DK2952178T3 (da) 2020-12-07

Family

ID=36218032

Family Applications (3)

Application Number Title Priority Date Filing Date
DK15176046.9T DK2952178T3 (da) 2004-11-16 2005-11-14 Oftalmiske sammensætninger og fremgangsmåder til behandling af øjne
DK05821259.8T DK1811959T4 (da) 2004-11-16 2005-11-14 Oftalmiske sammensætninger
DK10185764.7T DK2422765T3 (da) 2004-11-16 2005-11-14 Oftalmiske sammensætninger og fremgangsmåder til behandling af øjne

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK05821259.8T DK1811959T4 (da) 2004-11-16 2005-11-14 Oftalmiske sammensætninger
DK10185764.7T DK2422765T3 (da) 2004-11-16 2005-11-14 Oftalmiske sammensætninger og fremgangsmåder til behandling af øjne

Country Status (24)

Country Link
US (10) US8569367B2 (da)
EP (4) EP3777836A1 (da)
JP (1) JP5179880B2 (da)
KR (1) KR101344602B1 (da)
CN (1) CN101056618B (da)
AR (1) AR052031A1 (da)
AU (2) AU2005306721B2 (da)
BR (2) BR122019023144B8 (da)
CA (1) CA2588044C (da)
CY (2) CY1116545T1 (da)
DK (3) DK2952178T3 (da)
ES (3) ES2543974T3 (da)
HK (2) HK1107027A1 (da)
HU (2) HUE025116T2 (da)
IL (1) IL182532A (da)
NO (3) NO347855B1 (da)
NZ (2) NZ597106A (da)
PL (3) PL218364B1 (da)
PT (2) PT1811959E (da)
RU (1) RU2410081C2 (da)
SI (2) SI1811959T2 (da)
TW (1) TWI369996B (da)
WO (1) WO2006055454A2 (da)
ZA (1) ZA200702917B (da)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050147584A1 (en) * 2004-01-05 2005-07-07 Allergan, Inc. Compositions and methods comprising memantine and polyanionic polymers
US7220422B2 (en) * 2003-05-20 2007-05-22 Allergan, Inc. Methods and compositions for treating eye disorders
US8569367B2 (en) * 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
TW200722109A (en) * 2005-03-31 2007-06-16 Bausch & Lomb Polysaccharide and polyol composition for treating dry eye and related methods of manufacture and methods of use
TWI393567B (zh) 2005-03-31 2013-04-21 Bausch & Lomb 治療乾眼之組合物及相關之製造方法及使用方法
CA2611909C (en) * 2005-07-01 2014-01-07 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Composition for treatment of corneal disease
US20070004672A1 (en) * 2005-07-01 2007-01-04 Dharmendra Jani Long lasting alginate dry eye, related methods of manufacture and methods of use
CN1939534B (zh) * 2005-09-27 2010-12-01 长春金赛药业股份有限公司 含有人生长激素或人粒细胞巨噬细胞刺激因子的用于治疗损伤和溃疡的外用制剂
DE102005055275A1 (de) * 2005-11-17 2007-05-24 Ursapharm Arzneimittel Gmbh & Co. Kg Phosphatfreie pharmazeutische Zusammensetzung sowie deren Verwendung
US20080057022A1 (en) * 2006-08-30 2008-03-06 Erning Xia Ophthalmic Pharmaceutical Compositions and Uses Thereof
US20080095754A1 (en) * 2006-10-18 2008-04-24 Burke Susan E Ophthalmic compositions comprising diglycine
US8138156B2 (en) 2006-10-18 2012-03-20 Bausch & Lomb Incorporated Ophthalmic compositions containing diglycine
EA017752B1 (ru) * 2006-12-11 2013-02-28 Сигма-Тау Индустрие Фармасьютике Риуните С.П.А. Применение l-карнитина для получения лекарственного средства в форме глазных капель для лечения отека роговицы
DE102006060953A1 (de) * 2006-12-12 2008-08-07 Farco-Pharma Gmbh Pharmazeutische Zubereitung für die Behandlung entzündlicher Erkrankungen des Urogenitaltraktes
EP2101725A1 (en) * 2006-12-14 2009-09-23 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Use of l-carnitine or of alkanoyl l-carnitines for the preparation of a physiological supplement or medicament for ophthalmic use in the form of eye drops
US20080148689A1 (en) * 2006-12-20 2008-06-26 Bausch & Lomb Incorporated Packaging solutions
US8629099B2 (en) 2008-03-25 2014-01-14 Bausch & Lomb Incorporated Ophthalmic compositions comprising a dipeptide
EP2349232A1 (en) * 2008-10-20 2011-08-03 Allergan, Inc. Ophthalmic compositions useful for improving visual acuity
KR101778316B1 (ko) 2009-06-05 2017-09-13 알러간, 인코포레이티드 인공 눈물 및 치료학적 용도
ITMI20100319A1 (it) * 2010-02-26 2011-08-27 Lo Li Pharma Srl Composizioni comprendenti mioinositolo e il loro uso nel trattamento delle malattie respiratorie.
US9636355B2 (en) * 2011-09-22 2017-05-02 Theo Holdings, Llc Hypertonic dextran solution and methods of treating and preventing recurrent corneal erosion
US8957048B2 (en) * 2011-10-06 2015-02-17 Allergan, Inc. Compositions for the treatment of dry eye
PT2787969T (pt) * 2011-12-07 2021-11-09 Allergan Inc Entrega eficiente de lípidos para o filme lacrimal humano utilizando um sistema de emulsão sensível ao sal
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
JP6087374B2 (ja) * 2011-12-23 2017-03-01 ユニヴァーシティ オブ ウェスタン シドニー 眼科用製剤
US8664180B2 (en) 2012-02-06 2014-03-04 Bausch & Lomb Incorporated Ophthalmic compositions containing diglycine
US8324171B1 (en) 2012-02-06 2012-12-04 Bausch & Lomb Incorporated Ophthalmic compositions containing diglycine
WO2013142912A1 (en) 2012-03-30 2013-10-03 Brien Holden Vision Institute Methods and compositions for reducing ocular discomfort
BR112015018414B1 (pt) * 2013-02-01 2022-11-08 Allergan, Inc Lágrimas artificiais compreendendo hialuronato de sódio e carboximetilcelulose
CN107105724B (zh) 2014-08-20 2021-02-26 蚕丝科技有限公司 丝素衍生的蛋白质组合物
JP6768653B2 (ja) 2014-11-25 2020-10-14 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ 安定したオメガ−３眼科用組成物
ITUB20153104A1 (it) * 2015-08-13 2017-02-13 Sooft Italia S P A Contrada Molino 17 68333 Montegiorgio Fm Composizione ed uso di collirio a base di inositolo per migliorare l'accomodazione visiva dei pazienti
AU2016342057A1 (en) 2015-10-23 2018-03-01 The Trustees Of Columbia University In The City Of New York Laser induced collagen crosslinking in tissue
WO2017200659A2 (en) 2016-04-08 2017-11-23 Cornell University A method to enhance wound healing using silk-derived protein
WO2017214604A1 (en) 2016-06-10 2017-12-14 The Trustees Of Columbia University In The City Of New York Devices, methods, and systems for detection of collagen tissue features
RU2623205C1 (ru) * 2016-07-13 2017-06-22 Станислав Анатольевич Кедик Офтальмологический гель таурина
WO2018031973A1 (en) 2016-08-12 2018-02-15 Silk Technologies, Ltd. Silk-derived protein for treating inflammation
US11666481B1 (en) 2017-12-01 2023-06-06 The Trustees Of Columbia University In The City Of New York Diagnosis and treatment of collagen-containing tissues
CN111467349B (zh) * 2020-05-14 2021-06-01 华熙生物科技股份有限公司 人工泪液及其制备方法
US12239658B2 (en) 2021-03-10 2025-03-04 Bausch + Lomb Ireland Limited Preservative-free contact lens treating solution comprising hyaluronic acid and erythritol
US12012238B2 (en) * 2021-05-26 2024-06-18 Bausch + Lomb Ireland Limited Packaging solutions
WO2023034993A1 (en) * 2021-09-03 2023-03-09 Gleich Gerald J Compositions and methods for diagnosing, detecting and treating eosinophil-related diseases

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1781701A (en) 1928-05-16 1930-11-18 Phillips Morris Godfrey Philip Machine for removing flags and other adhering leaf from the stalks of tobacco leaves
US3278447A (en) 1963-12-02 1966-10-11 Cloro Bac Products Inc Process for stabilizing chlorine dioxide solution
US4201706A (en) * 1978-09-22 1980-05-06 Burton, Parsons & Company, Inc. Treatment of corneal edema
EP0028110B1 (en) 1979-10-26 1984-03-07 Smith and Nephew Associated Companies p.l.c. Autoclavable emulsions
EP0145710A1 (en) * 1983-05-25 1985-06-26 Alcon Laboratories, Inc. Ophthalmic solution
JPS6436255A (en) * 1987-07-31 1989-02-07 Fujitsu Ltd Feeding circuit
US5192535A (en) * 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
IT1235153B (it) 1988-11-15 1992-06-22 Sigma Tau Ind Farmaceuti Uso dell'acetil l-carnitina nel trattamento terapeutico della cataratta e composizioni farmaceutiche utili in tale trattamento
IT1224795B (it) * 1988-12-01 1990-10-24 Sigma Tau Ind Farmaceuti Uso dell'acetil d-carnitina nel trattamento terapeutico del glaucoma e composizioni farmaceutiche utili in tale trattamento
ES2038580T3 (es) 1989-08-03 1994-10-16 Eisai Co Ltd Metodo de fotoestabilizacion de soluciones oftalmicas.
US5681555A (en) * 1991-04-22 1997-10-28 Gleich; Gerald J. Method for the treatment of bronchial asthma by parenteral administration of anionic polymers
DE4229494A1 (de) * 1992-09-04 1994-03-10 Basotherm Gmbh Arzneimittel zur topischen Anwendung am Auge zur Behandlung des erhöhten intraokularen Drucks
JP3431216B2 (ja) 1993-06-18 2003-07-28 千代田化工建設株式会社 触媒層支持構造
KR970705985A (ko) 1994-09-14 1997-11-03 우에하라 아끼라 각막 장해 복구용 점안제(Eye Drops for Repairing Corneal Disturbance)
US5980865A (en) * 1995-08-18 1999-11-09 Baker Norton Pharmaceuticals, Inc. Method for treating late phase allergic reactions and inflammatory diseases
US5847294A (en) * 1996-04-09 1998-12-08 Amherst Process Instruments, Inc. Apparatus for determining powder flowability
JPH1036255A (ja) * 1996-07-24 1998-02-10 Nikken Chem Co Ltd 眼圧降下用点眼剤
IT1288399B1 (it) 1996-12-03 1998-09-22 Sigma Tau Ind Farmaceuti Medicamento per il trattamento terapeutico della maculopatia legata all'eta', della maculopatia non legata all'eta' e per la profilassi
FI106923B (fi) 1997-01-03 2001-05-15 Cultor Ltd Finnsugar Bioproduc Trimetyyliglysiinin käyttö kehon limakalvojen hygieniaan ja hoitoon tarkoitetuissa valmisteissa
AR002194A1 (es) 1997-03-17 1998-01-07 Sanchez Reynaldo Alemany Instrumento computarizado para el analisis del movimiento.
US6770675B2 (en) * 1997-03-17 2004-08-03 Novartis Ag Compositions and methods for reducing ocular hypertension
EP1021204B1 (en) 1997-09-26 2005-12-28 Noven Pharmaceuticals, Inc. Bioadhesive compositions and methods for topical administration of active agents
US6274725B1 (en) 1998-06-02 2001-08-14 Isis Pharmaceuticals, Inc. Activators for oligonucleotide synthesis
IT1302307B1 (it) * 1998-09-01 2000-09-05 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante ed atta a migliorarel'utilizzazione metabolica del glucosio, comprendente acetil
EP1131105B1 (en) * 1998-11-13 2004-08-11 Continental Projects Limited Complexes of hyaluronic acid/carnitines and pharmaceutical and cosmetic compositions
US6228392B1 (en) * 1999-04-29 2001-05-08 Gene Tools, Llc Osmotic delivery composition, solution, and method
KR100354606B1 (ko) 2000-02-01 2002-09-30 주식회사 중외제약 다목적 콘택트 렌즈 관리 용액 조성물
KR20030023700A (ko) * 2000-07-14 2003-03-19 알러간, 인코포레이티드 치료활성 성분을 함유하고 용해도가 증강된 조성물
AU781975B2 (en) * 2000-09-14 2005-06-23 Hayashibara Co., Ltd Pharmaceutical composition for ophthalmic use
US8557868B2 (en) 2000-11-04 2013-10-15 Fxs Ventures, Llc Ophthalmic and contact lens solutions using low molecular weight amines
PT1339418E (pt) 2000-11-08 2009-10-30 Fxs Ventures Llc Soluções oftálmicas e para lentes de contacto melhoradas contendo sacarídeos simples como intensificadores de conservação
US20030069410A1 (en) 2001-06-14 2003-04-10 Isis Pharmaceuticals, Inc. Methods for preparing oligonucleotides having chiral phosphorothioate linkages
AR036122A1 (es) 2001-07-03 2004-08-11 Avecia Biotechnology Inc Un complejo de sal que comprende un n-alquilimidazol y una 1,1-dioxo-1,2-dihidro-1l6-benzo [d]-isotiazol-3-ona y un metodo para sintetizar oligonucleotidos utilizando la quimica de fosforamidita
US6936589B2 (en) 2001-09-28 2005-08-30 Albert T. Naito Parenteral delivery systems
US7045121B2 (en) * 2001-12-14 2006-05-16 Allergan, Inc. Ophthalmic compositions for lubricating eyes and methods for making and using same
US6858614B2 (en) * 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenolic guanidine sodium channel blockers
AU2003259145A1 (en) 2002-07-17 2004-02-02 Spencer P. Thornton Treatment for dry eye syndrome
WO2004028536A1 (en) * 2002-09-30 2004-04-08 Babizhayev Mark A Method for topical treatment of eye disease and composition and device for said treatment
ITRM20020492A1 (it) 2002-10-01 2004-04-02 Sigma Tau Ind Farmaceuti Uso della propionil l-carnitina per la preparazione di un medicamento per il trattamento del glaucoma.
US20040137079A1 (en) 2003-01-08 2004-07-15 Cook James N. Contact lens and eye drop rewetter compositions and methods
WO2004084877A1 (ja) * 2003-03-26 2004-10-07 Menicon Co., Ltd. 眼科用組成物
US20050009836A1 (en) * 2003-06-26 2005-01-13 Laskar Paul A. Ophthalmic composition containing quinolones and method of use
US8569367B2 (en) * 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
BRPI0808410A2 (pt) 2007-02-28 2015-06-23 Aciex Therapeutics Inc Métodos e composições para normalizar secreções da glândula meibomiana
JP4929245B2 (ja) 2008-07-31 2012-05-09 株式会社ベッセル工業 工具類のグリップ
KR101778316B1 (ko) 2009-06-05 2017-09-13 알러간, 인코포레이티드 인공 눈물 및 치료학적 용도
US9907826B2 (en) * 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system

Also Published As

Publication number Publication date
ES2550616T3 (es) 2015-11-11
US8569367B2 (en) 2013-10-29
WO2006055454A2 (en) 2006-05-26
NZ583757A (en) 2011-11-25
BR122019023144B8 (pt) 2021-07-27
BRPI0518173A (pt) 2008-11-04
PL2422765T3 (pl) 2015-10-30
PT2422765E (pt) 2015-09-16
SI1811959T2 (sl) 2022-10-28
US20060106104A1 (en) 2006-05-18
CN101056618B (zh) 2015-02-11
HUE025116T2 (en) 2016-01-28
US20190365692A1 (en) 2019-12-05
HK1218620A1 (zh) 2017-03-03
CY1116936T1 (el) 2017-04-05
NO20072170L (no) 2007-08-15
EP2422765A1 (en) 2012-02-29
BRPI0518173B1 (pt) 2020-05-19
BRPI0518173A8 (pt) 2018-01-23
NO346214B1 (no) 2022-04-25
KR20070084264A (ko) 2007-08-24
EP1811959A2 (en) 2007-08-01
DK1811959T4 (da) 2022-06-27
BRPI0518173B8 (pt) 2021-05-25
US20180021282A1 (en) 2018-01-25
DK1811959T3 (da) 2015-11-23
CN101056618A (zh) 2007-10-17
EP2952178A1 (en) 2015-12-09
US20210401789A1 (en) 2021-12-30
US20140045773A1 (en) 2014-02-13
NZ597106A (en) 2013-06-28
TWI369996B (en) 2012-08-11
US20130190398A1 (en) 2013-07-25
NO20220060A1 (da) 2007-08-15
SI1811959T1 (sl) 2015-11-30
TW200631605A (en) 2006-09-16
EP2952178B1 (en) 2020-09-02
BR122019023144B1 (pt) 2021-02-09
PL218364B1 (pl) 2014-11-28
KR101344602B1 (ko) 2013-12-31
HK1107027A1 (zh) 2008-03-28
RU2007117637A (ru) 2008-12-27
ES2543974T3 (es) 2015-08-26
DK2422765T3 (da) 2015-08-03
US9254324B2 (en) 2016-02-09
RU2410081C2 (ru) 2011-01-27
US20140045939A1 (en) 2014-02-13
ES2550616T5 (es) 2022-09-29
US20230404961A1 (en) 2023-12-21
NO20240132A1 (no) 2007-08-15
AU2012203398A1 (en) 2012-06-28
CA2588044C (en) 2014-05-27
WO2006055454A3 (en) 2006-08-03
JP5179880B2 (ja) 2013-04-10
IL182532A0 (en) 2007-09-20
US8569370B2 (en) 2013-10-29
PL1811959T3 (pl) 2015-11-30
US20140256675A1 (en) 2014-09-11
IL182532A (en) 2013-10-31
US20160256424A1 (en) 2016-09-08
PT1811959E (pt) 2015-11-10
ES2842226T3 (es) 2021-07-13
CA2588044A1 (en) 2006-05-26
CY1116545T1 (el) 2017-03-15
US8729125B2 (en) 2014-05-20
AU2005306721B2 (en) 2012-03-08
EP2422765B1 (en) 2015-04-29
US9668997B2 (en) 2017-06-06
AR052031A1 (es) 2007-02-28
EP1811959B2 (en) 2022-06-15
PL383268A1 (pl) 2008-02-18
US10213405B2 (en) 2019-02-26
SI2422765T1 (sl) 2015-09-30
ZA200702917B (en) 2008-09-25
AU2012203398B2 (en) 2015-01-15
HUE026575T2 (en) 2016-06-28
NO347855B1 (no) 2024-04-22
AU2005306721A1 (en) 2006-05-26
EP3777836A1 (en) 2021-02-17
EP1811959B1 (en) 2015-09-02
JP2008520671A (ja) 2008-06-19

Similar Documents

Publication Publication Date Title
DK2952178T3 (da) Oftalmiske sammensætninger og fremgangsmåder til behandling af øjne
DK1830838T3 (da) Sammensætninger og fremgangsmåder til behandling af neoplastiske sygdomme
DK1805312T3 (da) Fremgangsmåder og midler til fremstilling af hyaluronan
DK1644021T3 (da) Fremgangsmåder og sammensætninger til behandlingen af gastrointestinale sygdomme
DK1917246T3 (da) Benzoquinazolinderivater og deres anvendelse til behandling af knoglesygdomme
FR2865631B1 (fr) Lunettes-masque
DK3714877T3 (da) Fremgangsmåde og sammensætning til behandling af okulær hypertension og glaukom
DK2460820T3 (da) PCV2-immunogene sammensætninger og fremgangsmåder til fremstilling af sådanne sammensætninger
ATE492272T1 (de) Therapeutische antimikrobielle zusammensetzungen und methoden
DK1888033T3 (da) Fremgangsmåde og sammensætning til behandling af inflammatoriske sygdomme
DK1765322T3 (da) Retinal-derivater og fremgangsmåder til anvendelse deraf i behandlingen af synsforstyrrelser
DK1713503T3 (da) Hæmning af faktor b, den alternative komplemenpathway og dertil relaterede fremgangsmåde
DK1768657T3 (da) Fremgangsmåder og sammensætninger til at behandle ophthalmiske tilstande med retinylderivater
DK1793855T4 (da) Forebyggelse og behandling af synukleinopatisk og amyloidogenisk sygdom
DK1928850T3 (da) Midler til forebyggelse og behandling af lidelser, der involverer modulering af RyR-receptorerne
NO20070251A (no) Brønnbehandling
NO20070297A (no) Brønnbehandling
DK1896077T3 (da) Fremgangsmåder og sammensætninger til forebyggelse og behandling af inflammatoriske sygdomme
DK1919290T3 (da) Fremgangsmåder og produkter til behandling af sygdomme
DK1629960T3 (da) Fremgangsmåde og forme til fremstilling af oftalmiske linser
FR2871247B1 (fr) Lentille ophtalmique
FR2868286B1 (fr) Lentille intra-oculaire perfectionnee
DK1791423T3 (da) Sammensætninger og fremgangsmåder til behandling af hyperproliferative dermatologiske tilstande
DK1611890T3 (da) Fremgangsmåde til evaluering og behandling af cancer
DK1812002T3 (da) Behandling af mastitis